Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 5, 1997, Pages 935-938

  Graham, D Y ^a,b   Huffman, J ^a   El Zimaity, H M T ^a   Graham, D P ^a   Osato, M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH; BISMUTH SALICYLATE; LANSOPRAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ADULT; ANOREXIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PEPTIC ULCER; PRIORITY JOURNAL; SMOKING; STOMACH PAIN; TABLET; TASTE DISORDER;

EID: 0030751497     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00219.x     Document Type: Article

References (29)

1. George LL, Borody TJ, Andrews P, et al Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145-9.
2. Graham DY, de Boer WA, Tytgat GN. Choosing the best antiHelicobacter pylori therapy: effect of antimicrobial resistance. Am] Gastroenterol 1996; 91: 1072-6.
3. Graham DY. A reliable cure for Helicobacter pylori infection? Gut 1995; 37: 154-6.
4. Graham DY. Determinants of antimicrobial effectiveness in II. pylori gastritis. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic mechanisms to clinical cure. Dordrecht: Kluwer Academic Publishers, 1994: 531-7.
5. Graham DY, Lew GM, Malaty HM. et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
6. van der Hülst RWM, Keller JJ, Rauws EA, Tytgat GNJ. Treatment of Helicobacter pylori infection in humans: a review of the world literature. Helicobacter 1996; 1: 6-19.
7. Penston JG. Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10: 469-86.
8. Penston JG. Helicobacter pylori eradication-understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
9. Borody TJ, George LL, Brandi S, et al. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol 1992; 27: 281.
10. Hosking SW, Ling TK, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992: 305: 502-i.
11. Bell GD, Powell Kü, Burridgc SM, et aL Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazolc compared with four alternative regimens. Q J Med 1993; 86: 743-50.
12. Hosking S\V, Ling TK. Chung SC. et al Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
13. Archimandritis A, Balatsos V, Delis V, Mentis A, Kastanas K, Scandalis N. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up. J Clin Gastroenterol 1995; 20: 12-6.
14. Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
15. Tucci A, Poli L, Gasperoni S, et al. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol 1994; 26: 107-10.
16. Xia H, Keane CT, Beattie S, O'Morain CA. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 1994; 38: 2357-61.
17. Borody TJ, Cole P, Koonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431-5.
18. Wilhelmsen I, Weberg R, Berstad K, Hausken T, Hundal 0, Berstad A. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepatogastroenterology 1994; 41: 43-7.
19. Berstad A, Berstad K, Hatlebakk JG, et al. 10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year. Tidsskr Nor Laegeforen 1994; 114: 2477-9.
20. de Boer WA. Tytgat GN. 90% cure: which anti-Helicobacter therapy can achieve this treatment goal? Am J Gastroenterol 1995; 90: 1381-2.
21. de Boer WA, Driessen WM, Jansz AR, Tytgat GN. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995; 7: 1189-94.
22. Tytgat GN. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
23. de Boer WA, van Etten RJ, Schade RW, Ouwehand ME, Schneeberger PM, Tytgat GN. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 1778-82.
24. de Boer WA. How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients. A personal viewpoint. J Clin Gastroenterol 1996; 22: 313-6.
25. Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996; 24: 37-41.
26. Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994: 25: 221-6.
27. 7 Klein PD, Malaty HM, Martin RF, Graham KS. Genta RM, Graham DY. Noninvasive detection of Helicobacter pylori infection in clinical practice: the I3C urea breath test. Am J Gastroenterol 1996; 91: 690-4.
28. de Boer WA. Thys JC, Borody TJ, Graham DY. O'Morain C, Tytgat GN. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol 1996: 8: 641-3.
29. Pagan T. Quickbasic program for exact and mid-P confidence intervals for a binomial proportion. Comput Biol Med 1996; 26: 263-7.